A citation-based method for searching scientific literature

Gunter von Minckwitz, Andreas Schneeweiss, Sibylle Loibl, Christoph Salat, Carsten Denkert, Mahdi Rezai, Jens U Blohmer, Christian Jackisch, Stefan Paepke, Bernd Gerber, Dirk M Zahm, Sherko Kümmel, Holger Eidtmann, Peter Klare, Jens Huober, Serban Costa, Hans Tesch, Claus Hanusch, Jörn Hilfrich, Fariba Khandan, Peter A Fasching, Bruno V Sinn, Knut Engels, Keyur Mehta, Valentina Nekljudova, Michael Untch. Lancet Oncol 2014
Times Cited: 548



Jessa Gilda P Pandy, Joanmarie C Balolong-Garcia, Mel Valerie B Cruz-Ordinario, Frances Victoria F Que. BMC Cancer 2019
Times Cited: 58




List of shared articles



Times cited

A meta-analysis of the effect and safety of platinum-based neoadjuvant chemotherapy in treatment of resectable triple-negative breast cancer.
Wuna Feng, Yujing He, Jingsi Xu, Hongya Zhang, Yuexiu Si, Jiaxuan Xu, Shengzhou Li. Anticancer Drugs 2022
2

A prospective phase II clinical trial identifying the optimal regimen for carboplatin plus standard backbone of anthracycline and taxane-based chemotherapy in triple negative breast cancer.
Caroline Hamm, Bre-Anne Fifield, Amin Kay, Swati Kulkarni, Rasna Gupta, John Mathews, Rosa-Maria Ferraiuolo, Huda Al-Wahsh, Emily Mailloux, Abdulkadir Hussein,[...]. Med Oncol 2022
1

Concurrent Chemo-radiation As a Means of Achieving Pathologic Complete Response in Triple Negative Breast Cancer.
Maryam Nemati Shafaee, Shalini Makawita, Bora Lim, Matthew J Ellis, Michelle S Ludwig. Clin Breast Cancer 2022
0

Moment of truth-adding carboplatin to neoadjuvant/adjuvant chemotherapy in triple negative breast cancer improves overall survival: An individual participant data and trial-level Meta-analysis.
Neha Pathak, Aparna Sharma, Arunmozhimaran Elavarasi, Jeeva Sankar, S V S Deo, Daya N Sharma, Sandeep Mathur, Sudhir Kumar, Chandra P Prasad, Akash Kumar,[...]. Breast 2022
2

Treatment for Triple-Negative Breast Cancer: An Umbrella Review of Meta-Analyses.
Jianyun Yin, Changtai Zhu, Gaofeng Wang, Jianwei Gu. Int J Gen Med 2022
0

Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline.
Larissa A Korde, Mark R Somerfield, Lisa A Carey, Jennie R Crews, Neelima Denduluri, E Shelley Hwang, Seema A Khan, Sibylle Loibl, Elizabeth A Morris, Alejandra Perez,[...]. J Clin Oncol 2021
107

Advances in Therapeutic Approaches for Triple-Negative Breast Cancer.
Reshma Mahtani, Muaiad Kittaneh, Kevin Kalinsky, Eleftherios Mamounas, Sunil Badve, Charles Vogel, Elyse Lower, Lee Schwartzberg, Mark Pegram. Clin Breast Cancer 2021
4

Neoadjuvant Chemotherapy of Triple-Negative Breast Cancer: Evaluation of Early Clinical Response, Pathological Complete Response Rates, and Addition of Platinum Salts Benefit Based on Real-World Evidence.
Milos Holanek, Iveta Selingerova, Ondrej Bilek, Tomas Kazda, Pavel Fabian, Lenka Foretova, Maria Zvarikova, Radka Obermannova, Ivana Kolouskova, Oldrich Coufal,[...]. Cancers (Basel) 2021
2